Title:
PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA, PREVENTING MYOPIA, AND/OR SUPPRESSING PROGRESSION OF MYOPIA
Document Type and Number:
WIPO Patent Application WO/2021/145355
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition for treating myopia, preventing myopia, and/or suppressing progression of myopia, the pharmaceutical composition containing omidenepag or an ester thereof, or a salt of these, as an active ingredient.
Inventors:
INABA TAKAAKI (JP)
SHIBAGAKI KEIICHI (JP)
MATSUOKA ISAO (JP)
HONDA KOHEI (JP)
SHIBAGAKI KEIICHI (JP)
MATSUOKA ISAO (JP)
HONDA KOHEI (JP)
Application Number:
PCT/JP2021/000952
Publication Date:
July 22, 2021
Filing Date:
January 14, 2021
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/444; A61K9/06; A61K9/08; A61K9/10; A61P27/06; A61P27/10
Domestic Patent References:
| WO2019131901A1 | 2019-07-04 | |||
| WO2019065838A1 | 2019-04-04 | |||
| WO2019124489A1 | 2019-06-27 |
Foreign References:
| JP2005289814A | 2005-10-20 |
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: